Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Self-Management

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Exercise Plus Acarbose Improves Diabetes Control Posted: Thursday, August 03, 2006

People with type 2 diabetes respond markedly to exercise, and adding acarbose to an exercise regimen significantly improves blood glucose control, exercise alone improve insullin sensitivity by 92 percent.

1 In 5 Youth With Diabetes Has Heart Risk Posted: Thursday, August 03, 2006

Overall roughly 20 percent of young people with diabetes (92% in those with type 2 and 14% in those with type 1) experience at least two additional cardiovascular disease risk factors, according to a new study.

Diabetes Treatment Benefits Dementia Posted: Friday, July 28, 2006

Diabetes and pre-diabetic conditions appear to increase the risk of Alzheimer's disease, but drugs that help regulate blood sugar may help patients with dementia as well, researchers report.

New Drug Slows Diabetic Nerve Damage Posted: Friday, July 28, 2006

The drug, epalrestat, delays the progression of diabetic peripheral neuropathy, as the condition is called, and ameliorates its symptoms.

Atorvastatin Lowers Cholesterol, But Does Not Prevent Cardiac Events in Diabetic Posted: Friday, July 21, 2006

Although atorvastatin therapy led to a significant reduction in mean LDL cholesterol level in patients with type 2 diabetes, there was no significant difference from placebo in cardiac events, such as cardiovascular death and myocardial infarction (MI).

Evening and Bedtime Second Dose Equal for Long-Acting Insulin Levemir Posted: Friday, July 14, 2006

Patients who take Levemir (insulin detemir) twice daily can chose a convenient evening time for their second dose.

Metformin Induces Long-Term Weight Loss in Teens Posted: Friday, July 07, 2006

Metformin can induce long-term weight loss in obese, non-diabetic adolescents, and could possibly be useful in a regimen to help achieve weight loss in adolescents, who may have developed type 2 diabetes type due to overweight.

New Drug Galvus Lowers A1c 2.8% Posted: Friday, June 23, 2006

Galvus, a new once-daily oral treatment option for type 2 diabetes, lowers A1c 2.8% and demonstrates impressive efficacy, especially in patients with poor glycemic control, as well as weight loss benefits in obese patients.

Ten Thousand Patients Using Levemir Insulin Show Improvements in BG Without Weight Gain Posted: Thursday, June 15, 2006

Levemir reduced mean A1C levels by 0.54 percent for type 1 and 0.89 percent for type 2 diabetes patients.

Mixing Long and Short Acting Insulins in Same Syringe Does Not Compromise Long-Term Glycemic Control Posted: Friday, June 09, 2006

Mixing Lantus and rapid-acting insulins as Humalog or Novolog does not compromise glycemic control.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.